In 2023, the UK alimentary tract and metabolism medicine sales stood at $2.72 billion. The forecasted data shows a gradual increase from 2024, reaching $2.84 billion by 2028. This reflects an average annual growth rate (CAGR) of approximately 0.89% over the five-year period between 2023 and 2028. Year-on-year growth remains steady, highlighting a stable market without sharp fluctuations.
Future trends to watch for include potential market expansions driven by innovation in therapeutics and increasing prevalence of digestive and metabolic disorders. Regulatory changes and healthcare policy reforms could also influence the sales trajectory in the coming years.
